Yeni tan ımlanan bir antite: Kombine pulmoner fibrozis ve amfizem sendromu

ÖZSU, Savaş; ÖZÇELİK, NESLİHAN

Yeni tan ımlanan bir antite: Kombine pulmoner fibrozis ve amfizem sendromu

Neslihan ÖZÇELİK, (Karadeniz Teknik Üniversitesi, Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, Trabzon, Türkiye)

Savaş ÖZSU (Karadeniz Teknik Üniversitesi, Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, Trabzon, Türkiye)

Tüberküloz ve Toraks

12 0

Yıl: 2015 Cilt: 63 Sayı: 1 Sayfa Aralığı: 48 - 52 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Yeni tan ımlanan bir antite: Kombine pulmoner fibrozis ve amfizem sendromu

Öz:

Kombine pulmoner fibrozis ve amfizem (CPFE) sendromu; nefes darlığı, üst lob amfizemi, alt lob fibrozisi ve gaz de ğişim bozuklu-ğuyla karakterize nadir bir hastalıktır. CPFE sendromu genellikle sigara içen erkeklerde görülür ve pulmoner hipertansiyon varlığımortaliteyle iliş kilidir. Spirometrik volümlerin nispeten korunması ve karbonmonoksit difüzyon testinde azalma diğer önemli birözelliktir. CPFE sendromu şimdiye kadar literatürde sadece 70 hastada tan ımlanm ıştır. Bu derlemede CPFE sendromu literatür e şli-ğinde sunulmu ştur.

Anahtar Kelime:

Konular: Solunum Sistemi Kulak, Burun, Boğaz

A newly-defined entity: Combined pulmonary fibrosis and emphysema syndrome

Öz:

Combined pulmonary fibrosis and emphysema (CPFE) syndrome is a rare disease characterized with shortness of breath, upper lobeemphysema, lower lobe fibrosis and impairment of gas exchange. This syndrome is a disease usually seen in male smokers.Pulmonary hypertension is associated with mortality. Another important feature, spirometric volumes relatively protected and areduction in carbon monoxide diffusion test. CPFE syndrome in the literature so far have been identified in only 70 patients. In thisreview CPFE syndrome is presented with literature.

Anahtar Kelime:

Konular: Solunum Sistemi Kulak, Burun, Boğaz

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık

1. Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med 1990;84(5):365-9.
2. Cottin V, Nunes H, Brillet PY, Delaval P, Devouassoux G, Tillie-Leblond I, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005;26(4):586-93.
3. Jankowich MD, Rounds SI. Combined pulmonary fibrosis and emphysema syndrome: a review. Chest 2012;141(1):222-31.
4. Alder JK, Guo N, Kembou F, Parry EM, Anderson CJ, Gorgy AI, et al. Telomere length is a determinant of emphysema susceptibility. Am J Respir Crit Care Med 2011;184(8):904- 12.
5. Akira M, Yamamoto S, Inoue Y, Sakatani M. High- resolution CT of asbestosis and idiopathic pulmonary fibro- sis. AJR Am J Roentgenol 2003;181(1):163-9.
6. Copley SJ, Wells AU, Sivakumaran P, Rubens MB, Lee YC, Desai SR, et al. Asbestosis and idiopathic pulmonary fibro- sis: comparison of thin-section CT features. Radiology 2003;229(3):731-6.
7. Heppleston AG. The pathological recognition and patho- genesis of emphysema and fibrocystic disease of the lung with special reference to coal workers. Ann N Y Acad Sci 1972;200:347-69.
8. Leigh J, Driscoll TR, Cole BD, Beck RW, Hull BP, Yang J. Quantitative relation between emphysema and lung min- eral content in coalworkers. Occup Environ Med 1994;51(6):400-7.
9. Wert SE, Yoshida M, LeVine AM, Ikegami M, Jones T, Ross GF, et al. Increased metalloproteinase activity, oxidant pro- duction, and emphysema in surfactant protein D gene-inac- tivated mice. Proc Natl Acad Sci USA 2000;97(11):5972-7.
10. Lappalainen U, Whitsett JA, Wert SE, Tichelaar JW, Bry K. Interleukin-1beta causes pulmonary inflammation, emphy- sema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol 2005;32(4):311-8.
11. Lundblad LK, Thompson-Figueroa J, Leclair T, Sullivan MJ, Poynter ME, Irvin CG, et al. Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. Am J Respir Crit Care Med 2005;171(12):1363-70.
12. Lucattelli M, Bartalesi B, Cavarra E, Fineschi S, Lunghi B, Martorana PA, et al. Is neutrophil elastase the missing link between emphysema and fibrosis? Evidence from two mouse models. Respir Res 2005;6:83.
13. Fulkerson PC, Fischetti CA, Hassman LM, Nikolaidis NM, and Rothenberg ME, Persistent effects induced by IL-13 in the lung. Am J Respir Cell Mol Biol 2006;35(3):337-46.
14. Epaud R, Delestrain C, Louha M, Simon S, Fanen P, Tazi A. Combined pulmonary fibrosis and emphysema syndrome associated with ABCA3 mutations. Eur Respir J 2014;43(2):638-41.
15. Cottin V, Cordier JF. Combined pulmonary fibrosis and emphysema in connective tissue disease. Curr Opin Pulm Med 2012;18(5):418-27.
16. Tzouvelekis A, Zacharis G, Oikonomou A, Koulelidis A, Steiropoulos P, Froudarakis M, et al. Combined pulmonary fibrosis and emphysema associated with microscopic poly- angiitis. Eur Respir J 2012;40(2):505-7.
17. Jankowich MD, Rounds S. Combined pulmonary fibrosis and emphysema alters physiology but has similar mortality to pulmonary fibrosis without emphysema. Lung 2010;188(5):365-73.
18. Lim TK. Respiratory failure from combined emphysema and pulmonary fibrosis. Singapore Med J 1993;34(2):169-71.
19. Kawabata Y, Hoshi E, Murai K, Ikeya T, Takahashi N, Saitou Y, et al. Smoking-related changes in the background lung of specimens resected for lung cancer: a semiquantita- tive study with correlation to postoperative course. Histopathology 2008;53(6):707-14.
20. Kitaguchi Y, Fujimoto K, Hanaoka M, Kawakami S, Honda T, Kubo K. Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology 2010;15(2):265-71.
21. Yousem, SA. Respiratory bronchiolitis-associated interstitial lung disease with fibrosis is a lesion distinct from fibrotic nonspecific interstitial pneumonia: a proposal. Mod Pathol 2006;19(11):1474-9.
22. Jankowich MD, Polsky M, Klein M, Rounds S. Heterogeneity in combined pulmonary fibrosis and emphysema. Respiration 2008;75(4):411-7.
23. Katzenstein AL, Mukhopadhyay S, Zanardi C, Dexter E. Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobec- tomy specimens. Hum Pathol 2010;41(3):316-25.
24. Akagi T, Matsumoto T, Harada T, Tanaka M, Kuraki T, Fujita M, et al. Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis. Respir Med 2009;103(8):1209-15.
25. Schmidt SL, Nambiar AM, Tayob N, Sundaram B, Han MK, Gross BH, et al. Pulmonary function measures predict mor- tality differently in IPF versus combined pulmonary fibrosis and emphysema. Eur Respir J 2011;38(1):176-83.
26. Doherty MJ, Pearson MG, O'Grady EA, Pellegrini V, Calverley PM. Cryptogenic fibrosing alveolitis with pre- served lung volumes. Thorax 1997;52(11):998-1002.
27. Hiwatari N, Shimura S, Takishima T. Pulmonary emphyse- ma followed by pulmonary fibrosis of undetermined cause. Respiration 1993;60(6):354-8.
28. Todd NW, Jeudy J, Lavania S, Franks TJ, Galvin JR, Deepak J, et al. Centrilobular emphysema combined with pulmo- nary fibrosis results in improved survival. Fibrogenesis Tissue Repair 2011;4(1):6.
29. Lee CH, Kim HJ, Park CM, Lim KY, Lee JY, Kim DJ, et al. The impact of combined pulmonary fibrosis and emphy- sema on mortality. Int J Tuberc Lung Dis 2011;15(8): 1111-6.
30. Kishaba T, Shimaoka Y, Fukuyama H, Yoshida K, Tanaka M, Yamashiro S, et al. A cohort study of mortality predic- tors and characteristics of patients with combined pulmo- nary fibrosis and emphysema. BMJ Open 2012;2(3).
31. Kwak N, Park CM, Lee J, Park YS, Lee SM, Yim JJ, et al. Lung cancer risk among patients with combined pulmonary fibrosis and emphysema. Respir Med 2014;108(3):524-30.
32. Usui K, Tanai C, Tanaka Y, Noda H, Ishihara T. The preva- lence of pulmonary fibrosis combined with emphysema in patients with lung cancer. Respirology 2011;16(2):326-31.
33. Cottin V, Le Pavec J, Prevot G, Mal H, Humbert M, Simonneau G, et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syn- drome. Eur Respir J 2010;35(1):105-11.
34. Cottin V. Clinical case: Combined pulmonary fibrosis and emphysema with pulmonary hypertension-clinical manage- ment. BMC Res Notes 2013;6(Suppl 1):S2.
35. Papiris SA, Triantafillidou C, Manali ED, Kolilekas L, Baou K, Kagouridis K, et al. Combined pulmonary fibrosis and emphy- sema. Expert Rev Respir Med 2013;7(1):19-31;quiz 32.
36. McGoon MD, Benza RL, Escribano-Subias P, Jiang X, Miller DP, Peacock AJ, et al. Pulmoner arter hipertansiyonu: Epidemiyoloji ve kay ıtlar. J Am Coll Cardiol 2013;62:D51-9.

APA	ÖZÇELİK N, ÖZSU S (2015). Yeni tan ımlanan bir antite: Kombine pulmoner fibrozis ve amfizem sendromu. , 48 - 52.
Chicago	ÖZÇELİK NESLİHAN,ÖZSU Savaş Yeni tan ımlanan bir antite: Kombine pulmoner fibrozis ve amfizem sendromu. (2015): 48 - 52.
MLA	ÖZÇELİK NESLİHAN,ÖZSU Savaş Yeni tan ımlanan bir antite: Kombine pulmoner fibrozis ve amfizem sendromu. , 2015, ss.48 - 52.
AMA	ÖZÇELİK N,ÖZSU S Yeni tan ımlanan bir antite: Kombine pulmoner fibrozis ve amfizem sendromu. . 2015; 48 - 52.
Vancouver	ÖZÇELİK N,ÖZSU S Yeni tan ımlanan bir antite: Kombine pulmoner fibrozis ve amfizem sendromu. . 2015; 48 - 52.
IEEE	ÖZÇELİK N,ÖZSU S "Yeni tan ımlanan bir antite: Kombine pulmoner fibrozis ve amfizem sendromu." , ss.48 - 52, 2015.
ISNAD	ÖZÇELİK, NESLİHAN - ÖZSU, Savaş. "Yeni tan ımlanan bir antite: Kombine pulmoner fibrozis ve amfizem sendromu". (2015), 48-52.

APA	ÖZÇELİK N, ÖZSU S (2015). Yeni tan ımlanan bir antite: Kombine pulmoner fibrozis ve amfizem sendromu. Tüberküloz ve Toraks, 63(1), 48 - 52.
Chicago	ÖZÇELİK NESLİHAN,ÖZSU Savaş Yeni tan ımlanan bir antite: Kombine pulmoner fibrozis ve amfizem sendromu. Tüberküloz ve Toraks 63, no.1 (2015): 48 - 52.
MLA	ÖZÇELİK NESLİHAN,ÖZSU Savaş Yeni tan ımlanan bir antite: Kombine pulmoner fibrozis ve amfizem sendromu. Tüberküloz ve Toraks, vol.63, no.1, 2015, ss.48 - 52.
AMA	ÖZÇELİK N,ÖZSU S Yeni tan ımlanan bir antite: Kombine pulmoner fibrozis ve amfizem sendromu. Tüberküloz ve Toraks. 2015; 63(1): 48 - 52.
Vancouver	ÖZÇELİK N,ÖZSU S Yeni tan ımlanan bir antite: Kombine pulmoner fibrozis ve amfizem sendromu. Tüberküloz ve Toraks. 2015; 63(1): 48 - 52.
IEEE	ÖZÇELİK N,ÖZSU S "Yeni tan ımlanan bir antite: Kombine pulmoner fibrozis ve amfizem sendromu." Tüberküloz ve Toraks, 63, ss.48 - 52, 2015.
ISNAD	ÖZÇELİK, NESLİHAN - ÖZSU, Savaş. "Yeni tan ımlanan bir antite: Kombine pulmoner fibrozis ve amfizem sendromu". Tüberküloz ve Toraks 63/1 (2015), 48-52.